Renal Cancer - Results from #140

Management of locally advanced renal cell carcinoma with invasion of the duodenum, "Beyond the Abstract," by Andrew T. Schlussel, DO and Linda L. Wong, MD January 11, 2014

A review of current management considerations for the incidentally detected small renal mass, "Beyond the Abstract," by Philippe E. Spiess, MD, MS, FRCS(C), FACS November 12, 2013

Association with disease-free and cancer-specific survival in lymphovascular invasion in clear cell renal cell carcinoma, "Beyond the Abstract," by Michael Belsante, MD November 7, 2013

Cumulative number of altered biomarkers in mTOR gene pathway is an independent predictor of outcome in patients with clear cell renal cell carcinoma, "Beyond the Abstract," by Oussama Darwish, MD and Vitaly Margulis, MD November 2, 2013

Pneumocystis pneumonia associated with everolimus therapy for renal cell carcinoma: A case report, "Beyond the Abstract," by Yoshinobu Saito, MD, PhD October 16, 2013

Pathological concordance and surgical outcomes of sporadic synchronous unilateral multifocal renal masses treated with partial nephrectomy, "Beyond the Abstract," by Robert Uzzo, MD, FACS, et al October 4, 2013

Coexistent metastatic melanoma of the kidney with unknown primary and renal cell carcinoma, "Beyond the Abstract," by Melinda B. Chu, MD and John M. Richart, MD October 3, 2013

Combined late gadolinium-enhanced and double-echo chemical-shift MRI help to differentiate renal oncocytomas with high central T2 signal intensity from renal cell carcinomas, "Beyond the Abstract," by François Cornelis, MD, et al. September 24, 2013

Effect of number and location of distant metastases on renal cell carcinoma mortality in candidates for cytoreductive nephrectomy: Implications for multimodal therapy, "Beyond the Abstract," by Umberto Capitanio, MD September 20, 2013

A case of tumor seeding at the time of ablative therapy for clinically localized renal cell carcinoma: A rare complication, "Beyond the Abstract," by Arash Akhavein, MD September 18, 2013

Fusion in urology, "Beyond the Abstract," by Hayet Amalou, MD September 17, 2013

Should mediastinal lymphadenectomy be performed during lung metastasectomy of renal cell carcinoma? "Beyond the Abstract," by Pierre-Emmanuel Falcoz, et al September 12, 2013

Why study carboxypeptidase M in the human kidney? Because it is there, "Beyond the Abstract," by Anne-Marie Lambeir September 4, 2013

Increased visceral obesity is associated with higher Fuhrman grade in patients with cT1a renal cell carcinoma, "Beyond the Abstract," by Hongkai Wang August 22, 2013

Analysis of surgical complications of renal tumor enucleation with standardized instruments and external validation of PADUA classification, "Beyond the Abstract," by Andrea Minervini, MD, PhD, et al August 12, 2013

Another look at treatment choices for metastatic renal cell carcinoma, "Beyond the Abstract," by Ghieth A. Kazkaz, et al. July 25, 2013

Short-term functional and oncological outcomes of partial nephrectomy for renal cell carcinoma in patients with an anatomically or functionally solitary kidney, "Beyond the Abstract," by Takeshi Maehana, MD, and Toshiaki Tanaka, MD July 18, 2013

Liver transplant techniques in surgical management of renal cell carcinoma with inferior vena cava thrombus, "Beyond the Abstract," by Michael Garcia-Roig, MD and Gaetano Ciancio, MD June 28, 2013

Preoperative evaluation of perinephric fat invasion in patients with renal cell carcinoma: Correlation with pathologic findings, "Beyond the Abstract," by Sandeep S. Hedgire, MD, et al June 25, 2013

Dual-tracer PET/CT in renal angiomyolipoma and subtypes of renal cell carcinoma, "Beyond the Abstract," by Kwan-Lun Ho, MBBS, Kossen Man Tzit Ho, MD, PhD, and Chi-lai Ho, MD June 22, 2013

Page 8 of 11